Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Inhalation therapy: help patients avoid these mistakes.

Self TH, Wallace JL, George CM, Howard-Thompson A, Schrock SD.

J Fam Pract. 2011 Dec;60(12):714-21. Review. No abstract available.

PMID:
22163353
2.

Training tools for inhalation devices: the need for more sophistication.

Azouz W, Campbell J, Chrystyn H.

Prim Care Respir J. 2011 Jun;20(2):221. doi: 10.4104/pcrj.2011.00036. No abstract available.

3.

Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma.

Capstick TG, Clifton IJ.

Expert Rev Respir Med. 2012 Feb;6(1):91-101; quiz 102-3. doi: 10.1586/ers.11.89. Review.

PMID:
22283582
4.

Changes in inhaler devices for asthma and COPD.

Capriotti T.

Medsurg Nurs. 2005 Jun;14(3):185-94. Review. No abstract available.

PMID:
16035636
5.

Inhaler devices for asthma and COPD: choice and technique.

Stevens N.

Prof Nurse. 2003 Jul;18(11):641-5. Review.

PMID:
12861818
6.

Inhalatory therapy training: a priority challenge for the physician.

Melani AS.

Acta Biomed. 2007 Dec;78(3):233-45. Review.

PMID:
18330086
8.

Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD.

Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, Dekhuijzen R, Sanchis J, Viejo JL, Barnes P, Corrigan C, Levy M, Crompton GK.

Respir Med. 2008 Apr;102(4):593-604. Epub 2007 Dec 20. Review.

9.

Inhaler use: tell patients to purse their lips.

Lubin D.

J Fam Pract. 2012 Mar;61(3):132. No abstract available.

PMID:
22493828
10.

Metered-dose inhaler technique per the Global Initiative for Asthma and Expert Panel Report 3: Why do pharmaceutical companies have one critical difference?

Self TH, Hoth LM, Bolin JM, Stewart C.

Ann Allergy Asthma Immunol. 2016 Jul;117(1):101-2. doi: 10.1016/j.anai.2016.05.002. Epub 2016 May 21. No abstract available.

PMID:
27221064
11.

[Therapy without success. Every 3d powder inhaler is used improperly (interview by Maria Weiss)].

Wieshammer S.

MMW Fortschr Med. 2007 Nov 29;149(48):8. German. No abstract available.

PMID:
18161431
12.

Challenges and opportunities in respiratory drug delivery devices.

Nikander K.

Expert Opin Drug Deliv. 2010 Nov;7(11):1235-8. doi: 10.1517/17425247.2010.525231. Epub 2010 Oct 12.

PMID:
20939686
13.

Drugs for asthma and COPD.

[No authors listed]

Treat Guidel Med Lett. 2013 Aug;11(132):75-86; quiz following 86. No abstract available.

PMID:
23896773
14.

Dry powder inhalers: which factors determine the frequency of handling errors?

Wieshammer S, Dreyhaupt J.

Respiration. 2008;75(1):18-25. Epub 2007 Oct 2.

PMID:
17911976
15.

[Inhalation therapy for asthma, and inhalation devices].

László K.

Acta Pharm Hung. 2010;80(4):173-7. Review. Hungarian.

PMID:
21404478
16.

[Inhalation techniques in the treatment of asthma].

Rodríguez M, Celay E, Larrea I, Urdánoz M, Zabalegui A, Ollo B.

An Sist Sanit Navar. 2003;26 Suppl 2:139-46. Spanish.

17.

[Nebuliser therapy].

Demir G, Saryal S.

Tuberk Toraks. 2003;51(3):325-32. Review. Turkish.

PMID:
15143414
18.

Determinants of an incorrect inhalation technique in patients with asthma or COPD.

Hesselink AE, Penninx BW, Wijnhoven HA, Kriegsman DM, van Eijk JT.

Scand J Prim Health Care. 2001 Dec;19(4):255-60.

PMID:
11822651
19.

Best evidence topic reports. BET 2: Should I use 2.5 mg or 5 mg nebulised salbutamol in acute exacerbations of COPD?

[No authors listed]

Emerg Med J. 2010 Oct;27(10):789-90. doi: 10.1136/emj.2010.101311. No abstract available.

PMID:
20852284
20.

[COPD and bronchial asthma. Therapy control leaves a lot to be desired].

Stiefelhagen P.

MMW Fortschr Med. 2013 Feb 7;155(2):21. German. No abstract available.

PMID:
23573738

Supplemental Content

Support Center